2M1N
Solution structure of a chaperone in type III secretion system
Summary for 2M1N
| Entry DOI | 10.2210/pdb2m1n/pdb |
| NMR Information | BMRB: 18871 |
| Descriptor | Type III secretion system filament chaperone CesA (1 entity in total) |
| Functional Keywords | helix bundle, chaperone |
| Biological source | Escherichia coli |
| Total number of polymer chains | 2 |
| Total formula weight | 24520.26 |
| Authors | Chen, L.,Economou, A.,Kalodimos, C. (deposition date: 2012-12-03, release date: 2013-04-10, Last modification date: 2024-05-15) |
| Primary citation | Chen, L.,Ai, X.,Portaliou, A.G.,Minetti, C.A.,Remeta, D.P.,Economou, A.,Kalodimos, C.G. Substrate-Activated Conformational Switch on Chaperones Encodes a Targeting Signal in Type III Secretion. Cell Rep, 3:709-715, 2013 Cited by PubMed Abstract: The targeting of type III secretion (TTS) proteins at the injectisome is an important process in bacterial virulence. Nevertheless, how the injectisome specifically recognizes TTS substrates among all bacterial proteins is unknown. A TTS peripheral membrane ATPase protein located at the base of the injectisome has been implicated in the targeting process. We have investigated the targeting of the EspA filament protein and its cognate chaperone, CesAB, to the EscN ATPase of the enteropathogenic E. coli (EPEC). We show that EscN selectively engages the EspA-loaded CesAB but not the unliganded CesAB. Structure analysis revealed that the targeting signal is encoded in a disorder-order structural transition in CesAB that is elicited only upon the binding of its physiological substrate, EspA. Abrogation of the interaction between the CesAB-EspA complex and EscN resulted in severe secretion and infection defects. Additionally, we show that the targeting and secretion signals are distinct and that the two processes are likely regulated by different mechanisms. PubMed: 23523349DOI: 10.1016/j.celrep.2013.02.025 PDB entries with the same primary citation |
| Experimental method | SOLUTION NMR |
Structure validation
Download full validation report






